TG01/GM-CSF and adjuvant gemcitabine in patients with resected RAS-mutant adenocarcinoma of the pancreas (CT TG01-01): a single-arm, phase 1/2 trial

British Journal of Cancer, Published online: 17 February 2020; doi:10.1038/s41416-020-0752-7TG01/GM-CSF and adjuvant gemcitabine in patients with resected RAS-mutant adenocarcinoma of the pancreas (CT TG01-01): a single-arm, phase 1/2 trial

Source: British Journal of Cancer - February 16, 2020 Category: Cancer & Oncology Authors: Daniel H. Palmer Juan W. Valle Yuk Ting Ma Olusola Faluyi John P. Neoptolemos Trine Jensen Gjertsen Berit Iversen Jon Amund Eriksen Anne-Sophie M øller Anne-Kirsti Aksnes Robert Miller Svein Dueland Source Type: research